Trump, Harris plans on drug costs, abortion, Obamacare differ
President Donald Trump talks to the press outside the White House, July 19, 2019, left, and Democratic presidential nominee and ...
Tag: Pharmaceuticals
Dividend-paying health-care stocks could be in early days of a rally
It's time to step back into health-care stocks, according to Wolfe Research. The sector was one of the worst performing ...
U.S. FDA to reconsider decision barring compounded versions of Lilly weight loss drug
Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain.Cristina Arias | Cover | Getty ImagesThe U.S. Food and ...
Pfizer threatened renegade executives before schism: Starboard’s Smith
Ian Read, chairman and chief executive officer of Pfizer Inc., gestures as he speaks during a panel session at the ...
Starboard Value has $1 billion Pfizer stake, taps former exec for help
People pass by the Pfizer headquarters building in New York City, Jan. 29, 2023.Kena Betancur | View Press | Corbis ...
Blockbuster weight-loss drug supply hit in trade shutdown
An Eli Lilly & Co. Zepbound injection pen, March 28, 2024.Bloomberg | Bloomberg | Getty ImagesAs a port strike stretching ...
CVS is working with advisors on strategic review, sources say
CVS Pharmacy logo is seen in Washington DC, United States on July 9, 2024. Jakub Porzycki | Nurphoto | Getty ImagesCVS ...
FDA approves Bristol Myers Squibb’s schizophrenia drug
Bristol Myers Squibb's Cobenfy drugCourtesy: Bristol Myers SquibbThe Food and Drug Administration on Thursday approved Bristol Myers Squibb's highly anticipated ...
Novo Nordisk CEO to testify at Senate over weight loss drug prices
Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on Aug. 10, 2022.Christopher Goodney | ...
FTC sues drug middlemen for allegedly inflating insulin prices
Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee at the Rayburn House Office ...
Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says
The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to enter into the "frenzy" of ...
Pfizer’s cancer cachexia drug shows positive midstage trial results
Pfizer's experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive ...
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!